首页   按字顺浏览 期刊浏览 卷期浏览 Ampicillin in the Treatment of Preterm Labor: A Randomised, Placebo-Controlled Study
Ampicillin in the Treatment of Preterm Labor: A Randomised, Placebo-Controlled Study

 

作者: Ruta Nadisauskiene,   Staffan Bergström,   Antanas Kilda,  

 

期刊: Gynecologic and Obstetric Investigation  (Karger Available online 1996)
卷期: Volume 41, issue 2  

页码: 89-92

 

ISSN:0378-7346

 

年代: 1996

 

DOI:10.1159/000292049

 

出版商: S. Karger AG

 

关键词: Randomised study;Preterm labor;Preterm birth;Ampicillin

 

数据来源: Karger

 

摘要:

This study was performed in order to assess whether the use of oral ampicillin vs. placebo therapy in women with latent-phase preterm labor delays delivery and improves pregnancy outcome. A prospective, randomised, double-blind, placebo-controlled study was performed of 110 women at 22–34 weeks of gestation. Patients received oral ampicillin 1 g (n = 59) or placebo (n = 51) every 8 h for 7 days. Outcome measures comprised gestational age at delivery, birth weight, Apgar score, perinatal death, neonatal infection, fetal growth restriction, histological chorioamnionitis and puerperal infection. In the ampicillin and placebo groups, respectively, the average gestational age at birth was 36.6 and 33.8 weeks (p < 0.05) and average birth weight 2,885 and 2,336 g (p 35 weeks and for birth weight ≧2,500g was 3.9 (95% CI 1.6-9.4). Neonatal infection (OR 15.5; 95% CI 4.6–65.7), intrauterine growth retardation (OR 9.6; 95% CI 2.8–41.3), histological chorioamnionitis (OR 13.0; 95% CI 3.4–72.2) and puerperal endometritis-myometritis (OR 65.3; 95% CI 9.3–2,715.7) occurred significantly less frequently among ampicillin-treated than among placebo-treated women. It is concluded that women in latent phase of preterm labor benefit from treatment with oral ampicillin, which prolongs the gestational age at delivery with ensuing increase in birth weight, reduction in the prevalence of histological chorioamnionitis and in neonatal and puerperal infectiou

 

点击下载:  PDF (1758KB)



返 回